Involving Pregnant Individuals in Clinical Research on COVID-19 Vaccines
- PMID: 33566088
- PMCID: PMC10080263
- DOI: 10.1001/jama.2021.1865
Involving Pregnant Individuals in Clinical Research on COVID-19 Vaccines
Conflict of interest statement
References
-
- Zambrano LD, Ellington S, Strid P, et al.; CDC COVID-19 Response Pregnancy and Infant Linked Outcomes Team. Update: characteristics of symptomatic women of reproductive age with laboratory-confirmed SARS-CoV-2 infection by pregnancy status—United States, January 22-October 3, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(44):1641–1647. doi:10.15585/mmwr.mm6944e3 - DOI - PMC - PubMed
-
- Metz TD. Maternal and neonatal outcomes of pregnant patients with coronavirus disease 2019 (COVID-19): a multistate cohort. Am J Obstet Gynecol. 2021;224(2):S722–S723. doi:10.1016/j.ajog.2020.12.1204 - DOI
-
- Pfizer-BioNTech COVID-19 vaccine (BNT162,PF-07302048). Vaccines and Related Biological Products Advisory Committee briefing document. December 10, 2020. Accessed January 31, 2021. https://www.fda.gov/media/144246/download
-
- ModernaTx Inc. Moderna COVID-19 vaccine. Vaccines and Related Biological Products Advisory Committee FDA briefing document. December 17, 2020. Accessed January 31, 2021. https://www.fda.gov/media/144434/download
-
- CDC. Ensuring the safety of COVID-19 vaccines in the United States. Updated January 28, 2021. Accessed January 31, 2021. https://www.cdc.gov/coronavirus/2019-ncov/vaccines/safety.html
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical